Takeda Pharmaceutical Co., Ltd.

Japan

  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
Aug 16, 2017
Prev close: 5,974
Aug 16, 2017
Market cap:
Market cap(USD):
4,724.02B
42,614.48M
Shares: 790.76M

Currency in JPY

Company profile

Market(Ticker): TKS(4502)
Sector:
Industry:
Health Technology
Pharmaceuticals: Major
Full time employees: 29,900

Business summary

Takeda Pharmaceutical Co., Ltd. is a research-based global pharmaceutical company that engages in the manufacture, sale, import, export, and marketing of pharmaceutical drugs. It operates through the following segments: Ethical Drug, Consumer Healthcare, and Others. The Ethical Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Others segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

In the news

Financial highlights

Mar 2017

  • Local currency
  • US Dollar
Revenue 1,732.05B
Gross profit 1,061.91B
Operating income 131,230M
Income before tax 144,892M
Net income 114,940M
EBITDA 301,735M
Diluted EPS 146.25
Dividends per share 180
Total assets 4,355.78B
Total liabilities 2,406.81B
Total equity 1,894.26B
Operating cash flow 260,067M

Currency in JPY

Revenue 15,994.93M
Gross profit 9,806.45M
Operating income 1,211.86M
Income before tax 1,338.03M
Net income 1,061.43M
EBITDA 2,786.42M
Diluted EPS 1.35
Dividends per share 1.66
Total assets 39,089.84M
Total liabilities 21,599.37M
Total equity 16,999.56M
Operating cash flow 2,401.63M

Currency in USD

Valuation measures

Mar 2017

PER 35.53
ROA 2.81%
ROE 5.98%
Operating margin 7.57%
Profit margin 6.63%

Key executive

  • President, CEO & Representative Director: Christophe Weber
  • Director, Chief Financial & Corporate Officer: James Kehoe
  • Director, Chief Medical & Scientific Officer: Andrew S. Plump
  • Manager-Research & Development: Shinji Ninomiya
  • Executive Officer & Global General Counsel: Yoshihiro Nakagawa

Share holders

  • Nippon Life Insurance Co.(6.4%)
  • Capital Research & Management Co. (Global Investors)(3.3%)
  • Nomura Asset Management Co., Ltd.(2.7%)
  • Takeda Science Foundation(2.2%)
  • The Vanguard Group, Inc.(2.1%)
  • Wellington Management Co. LLP(1.5%)
  • BlackRock Fund Advisors(1.5%)
  • Capital Research & Management Co. (World Investors)(1.2%)
  • Nikko Asset Management Co., Ltd.(1.2%)
  • Daiwa Asset Management Co. Ltd.(1.2%)

Address

  • Website: http://www.takeda.co.jp
  • Address: 4-1-1 Dosho-machi, Chuo-Ku, Osaka, 540-8645, Japan
  • Phone: +81.6.6204.2111

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.